213 related articles for article (PubMed ID: 2459161)
1. A juxta-membrane epitope on the human acetylcholine receptor recognized by T cells in myasthenia gravis.
Harcourt GC; Sommer N; Rothbard J; Willcox HN; Newsom-Davis J
J Clin Invest; 1988 Oct; 82(4):1295-300. PubMed ID: 2459161
[TBL] [Abstract][Full Text] [Related]
2. Peptide-selected T cell lines from myasthenia gravis patients and controls recognize epitopes that are not processed from whole acetylcholine receptor.
Matsuo H; Batocchi AP; Hawke S; Nicolle M; Jacobson L; Vincent A; Newsom-Davis J; Willcox N
J Immunol; 1995 Oct; 155(7):3683-92. PubMed ID: 7561069
[TBL] [Abstract][Full Text] [Related]
3. Specificity of the T cell immune response to acetylcholine receptor in experimental autoimmune myasthenia gravis. Response to subunits and synthetic peptides.
Fujii Y; Lindstrom J
J Immunol; 1988 Mar; 140(6):1830-7. PubMed ID: 2450133
[TBL] [Abstract][Full Text] [Related]
4. Myasthenia gravis. T epitopes on the delta subunit of human muscle acetylcholine receptor.
Protti MP; Manfredi AA; Wu XD; Moiola L; Howard JF; Conti-Tronconi BM
J Immunol; 1991 Apr; 146(7):2253-61. PubMed ID: 1706391
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune responses against acetylcholine receptor: T and B cell collaboration and manipulation by synthetic peptides.
Atassi MZ; Oshima M
Crit Rev Immunol; 1997; 17(5-6):481-95. PubMed ID: 9419435
[TBL] [Abstract][Full Text] [Related]
6. T cell epitopes in experimental autoimmune myasthenia gravis of the rat: strain-specific epitopes and cross-reaction between two distinct segments of the alpha chain of the nicotinic acetylcholine receptor (Torpedo californica).
Zhang Y; Barkas T; Juillerat M; Schwendimann B; Wekerle H
Eur J Immunol; 1988 Apr; 18(4):551-7. PubMed ID: 2452743
[TBL] [Abstract][Full Text] [Related]
7. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
Atassi MZ; Oshima M; Deitiker P
Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597
[TBL] [Abstract][Full Text] [Related]
8. Immunological heterogeneity of autoreactive T lymphocytes against the nicotinic acetylcholine receptor in myasthenic patients.
Zhang Y; Schluep M; Frutiger S; Hughes GJ; Jeannet M; Steck A; Barkas T
Eur J Immunol; 1990 Dec; 20(12):2577-83. PubMed ID: 2269325
[TBL] [Abstract][Full Text] [Related]
9. Determinant selection in murine experimental autoimmune myasthenia gravis. Effect of the bm12 mutation on T cell recognition of acetylcholine receptor epitopes.
Infante AJ; Thompson PA; Krolick KA; Wall KA
J Immunol; 1991 May; 146(9):2977-82. PubMed ID: 1707927
[TBL] [Abstract][Full Text] [Related]
10. T-cell recognition of acetylcholine receptor provides a reliable means for monitoring autoimmunity to acetylcholine receptor in antibody-negative myasthenia gravis patients.
Oshima M; Deitiker PR; Smith RG; Mosier D; Atassi MZ
Autoimmunity; 2012 Mar; 45(2):153-60. PubMed ID: 21985279
[TBL] [Abstract][Full Text] [Related]
11. TCR V beta usage by acetylcholine receptor-specific CD4+ T cells in myasthenia gravis.
Raju R; Navaneetham D; Protti MP; Horton RM; Hoppe BL; Howard J; Conti-Fine BM
J Autoimmun; 1997 Apr; 10(2):203-17. PubMed ID: 9185882
[TBL] [Abstract][Full Text] [Related]
12. Response of CD4+ T cells from myasthenic patients and healthy subjects of biosynthetic and synthetic sequences of the nicotinic acetylcholine receptor.
Diethelm-Okita B; Wells GB; Kuryatov A; Okita D; Howard J; Lindstrom JM; Conti-Fine BM
J Autoimmun; 1998 Apr; 11(2):191-203. PubMed ID: 9650099
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune T lymphocytes in myasthenia gravis. Determination of target epitopes using T lines and recombinant products of the mouse nicotinic acetylcholine receptor gene.
Melms A; Chrestel S; Schalke BC; Wekerle H; Mauron A; Ballivet M; Barkas T
J Clin Invest; 1989 Mar; 83(3):785-90. PubMed ID: 2466050
[TBL] [Abstract][Full Text] [Related]
14. Myasthenia gravis. Residues of the alpha and gamma subunits of muscle acetylcholine receptor involved in formation of immunodominant CD4+ epitopes.
Moiola L; Protti MP; McCormick D; Howard JF; Conti-Tronconi BM
J Immunol; 1994 May; 152(9):4686-98. PubMed ID: 7908921
[TBL] [Abstract][Full Text] [Related]
15. Genetic restriction of autoreactive acetylcholine receptor-specific T lymphocytes in myasthenia gravis.
Hohlfeld R; Conti-Tronconi B; Kalies I; Bertrams J; Toyka KV
J Immunol; 1985 Oct; 135(4):2393-9. PubMed ID: 2411794
[TBL] [Abstract][Full Text] [Related]
16. Scanning a DRB3*0101 (DR52a)-restricted epitope cross-presented by DR3: overlapping natural and artificial determinants in the human acetylcholine receptor.
Nagvekar N; Corlett L; Jacobson LW; Matsuo H; Chalkley R; Driscoll PC; Deshpande S; Spack EG; Willcox N
J Immunol; 1999 Apr; 162(7):4079-87. PubMed ID: 10201931
[TBL] [Abstract][Full Text] [Related]
17. A 17-Mer self-peptide of acetylcholine receptor binds to B cell MHC class II, activates helper T cells, and stimulates autoantibody production and electrophysiologic signs of myasthenia gravis.
Yoshikawa H; Lambert EH; Walser-Kuntz DR; Yasukawa Y; McCormick DJ; Lennon VA
J Immunol; 1997 Aug; 159(3):1570-7. PubMed ID: 9233656
[TBL] [Abstract][Full Text] [Related]
18. B-T lymphocyte interactions in experimental autoimmune myasthenia gravis: autoantibody mediated up-regulation of the response of acetylcholine receptor-specific T lymphocytes.
Zhang Y; Tzartos S
Immunology; 1992 Dec; 77(4):571-6. PubMed ID: 1283599
[TBL] [Abstract][Full Text] [Related]
19. T cells from normal and myasthenic individuals recognize the human acetylcholine receptor: heterogeneity of antigenic sites on the alpha-subunit.
Melms A; Malcherek G; Gern U; Wiethölter H; Müller CA; Schoepfer R; Lindstrom J
Ann Neurol; 1992 Mar; 31(3):311-8. PubMed ID: 1379027
[TBL] [Abstract][Full Text] [Related]
20. Responses in vitro of peripheral blood lymphocytes from patients with myasthenia gravis to stimulation with human acetylcholine receptor alpha-chain peptides: analysis in relation to age, thymic abnormality, and ethnicity.
Oshima M; Deitiker PR; Mosier DR; Smith RG; Atassi MZ
Hum Immunol; 2005 Jan; 66(1):32-42. PubMed ID: 15620460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
